NanJing Pharmaceutical Co Ltd
SSE:600713
NanJing Pharmaceutical Co Ltd
Total Current Assets
NanJing Pharmaceutical Co Ltd
Total Current Assets Peer Comparison
Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
NanJing Pharmaceutical Co Ltd
SSE:600713
|
Total Current Assets
¥26B
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
11%
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Total Current Assets
¥372.2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Total Current Assets
¥162.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
10%
|
CAGR 10-Years
14%
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Total Current Assets
¥75.6B
|
CAGR 3-Years
4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
16%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Total Current Assets
¥28.3B
|
CAGR 3-Years
9%
|
CAGR 5-Years
8%
|
CAGR 10-Years
21%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Total Current Assets
¥18.5B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
10%
|
See Also
What is NanJing Pharmaceutical Co Ltd's Total Current Assets?
Total Current Assets
26B
CNY
Based on the financial report for Mar 31, 2024, NanJing Pharmaceutical Co Ltd's Total Current Assets amounts to 26B CNY.
What is NanJing Pharmaceutical Co Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
11%
Over the last year, the Total Current Assets growth was -15%. The average annual Total Current Assets growth rates for NanJing Pharmaceutical Co Ltd have been 4% over the past three years , 5% over the past five years , and 11% over the past ten years .